DNA-based vaccination against hepatitis B virus using dissolving microneedle arrays adjuvanted by cationic liposomes and CpG ODN

Drug Delivery

Volumn 23, Issue 7, 2016, Pages 2391-2398

  Qiu, Yuqin ^a   Guo, Lei ^a   Zhang, Suohui ^a   Xu, Bai ^a   Gao, Yunhua ^a   Hu, Yan ^b   Hou, Jun ^b   Bai, Bingke ^b   Shen, Honghui ^b   Mao, Panyong ^b  

^a TECHNICAL INSTITUTE OF PHYSICS AND CHEMISTRY   (China)

^b BEIJING 302 HOSPITAL   (China)

Author keywords

Adjuvants; dissolving microneedle arrays; DNA vaccine; hepatitis B virus; transcutaneous immunization

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; DNA VACCINE; GREEN FLUORESCENT PROTEIN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; LIPOSOME; CATION; CPG-OLIGONUCLEOTIDE; DNA; IMMUNOLOGICAL ADJUVANT; OLIGODEOXYRIBONUCLEOTIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DISSOLUTION; DNA IMMUNIZATION; FEMALE; GENE EXPRESSION; HEPATITIS B VIRUS; IMMUNE RESPONSE; IMMUNOGENICITY; IN VIVO STUDY; MICRONEEDLE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TH1 TH2 BALANCE; ANIMAL; CHEMISTRY; CUTANEOUS DRUG ADMINISTRATION; DRUG EFFECTS; HUMORAL IMMUNITY; IMMUNOLOGY; METABOLISM; SKIN;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, CUTANEOUS; ANIMALS; CATIONS; DNA; HEPATITIS B VACCINES; HEPATITIS B VIRUS; IMMUNITY, HUMORAL; LIPOSOMES; MICE; OLIGODEOXYRIBONUCLEOTIDES; SKIN;

EID: 84991581735     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717544.2014.992497     Document Type: Article

References (23)

1. D.Christensen, E.M.Agger, L.V.Andreasen,. (2009). Liposome-based cationic adjuvant formulations (CAF):past, present, and future. J Liposome Res 19:2–11
2. R.L.Coffman, D.A.Lebman, P.Rothman. (1993). Mechanism and regulation of immunoglobulin isotype switching. Adv Immunol 54:229–70
3. S.L.Constant, K.Bottomly. (1997). Induction of Th1 and Th2 CD4+ T cell responses:the alternative approaches. Annu Rev Immunol 15:297–322
4. H.L.Davis, M.J.McCluskie, J.L.Gerin, R.H.Purcell. (1996). DNA vaccine for hepatitis B:Evidence for immunogenicity in chimpanzees and comparison with other vaccines. Proc Natl Acad Sci USA 93:7213–18
5. J.Donnelly, K.Berry, J.B.Ulmer. (2003). Technical and regulatory hurdles for DNA vaccines. Int J Parasitol 33:457–67
6. B.Ferraro, M.P.Morrow, N.A.Hutnick,. (2011). Clinical applications of DNA vaccines:current progress. Clin Infect Dis 53:296–302
7. H.S.Gill, M.R.Prausnitz. (2007). Coated microneedles for transdermal delivery. J Control Release 117:227–37
8. L.Guo, J.M.Chen, Y.Q.Qiu,. (2013b). Enhanced transcutaneous immunization via dissolving microneedle array loaded with liposome encapsulated antigen and adjuvant. Int J Pharmaceut 447:22–30
9. L.Guo, Y.Q.Qiu, J.M.Chen,. (2013a). Effective transcutaneous immunization against hepatitis B virus by a combined approach of hydrogel patch formulation and microneedle arrays. Biomed Microdevices 15:1077–85
10. I.Gursel, M.Gursel, K.J.Ishii, D.M.Klinman. (2001). Sterically stabilized cationic liposomes improve the uptake and immunostimulatory activity of CpG oligonucleotides. J Immunol 167:3324–8
11. J.H.Hoofnagle, A.M.DiBisceglie. (1997). The treatment of chronic viral hepatitis. New Engl J Med 336:347–56
12. D.M.Klinman, A.K.Yi, S.L.Beaucage,. (1996). CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma. Proc Natl Acad Sci USA 93:2879–83
13. T.S.Kupper, R.C.Fuhlbrigge. (2004). Immune surveillance in the skin:mechanisms and clinical consequences. Nat Rev Immunol 4:211–22
14. N.Li, C.Y.Zhuang, M.Wang,. (2012). Low molecular weight chitosan-coated liposomes for ocular drug delivery:In vitro and in vivo studies. Drug Deliv 19:28–35
15. M.L.Michel, D.Loirat. (2001). DNA vaccines for prophylactic or therapeutic immunization against hepatitis B. Intervirology 44:78–87
16. S.Moon, Y.H.Wang, C.Edens,. (2013). Dose sparing and enhanced immunogenicity of inactivated rotavirus vaccine administered by skin vaccination using a microneedle patch. Vaccine 31:3396–402
17. N.Pavselj, V.Preat. (2005). DNA electrotransfer into the skin using a combination of one high- and one low-voltage pulse. J Control Release 106:407–15
18. M.Pearton, S.M.Kang, J.M.Song,. (2010). Influenza virus-like particles coated onto microneedles can elicit stimulatory effects on Langerhans cells in human skin. Vaccine 28:6104–13
19. S.P.Sullivan, D.G.Koutsonanos, M.D.Martin,. (2010). Dissolving polymer microneedle patches for influenza vaccination. Nat Med 16:915–20
20. J.H.Van den Berg, B.Nuijen, J.H.Beijnen,. (2009). Optimization of intradermal vaccination by DNA tattooing in human skin. Hum Gene Ther 20:181–9
21. K.Van der Maaden, W.Jiskoot, J.Bouwstra. (2012). Microneedle technologies for (trans)dermal drug and vaccine delivery. J Control Release 161:645–55
22. G.Yan, N.Arelly, N.Farhan,. (2014). Enhancing DNA delivery into the skin with a motorized microneedle device. Eur J Pharm Sci 52:215–22
23. D.F.Yin, W.Q.Liang, S.X.Xing,. (2013). Hepatitis B DNA vaccine-polycation nano-complexes enhancing immune response by percutaneous administration with microneedle. Biol Pharm Bull 36:1283–91